logo
University of Surrey report urges rethink over future water use

University of Surrey report urges rethink over future water use

BBC News17-07-2025
Customers and the water industry must work together to reduce water use, an academic study has found.Experts from the University of Surrey's Institute for Sustainability have been working with more than 100 professionals, including some from nine UK water companies.The university's report said companies should do more to understand how their customers use water, before helping them change their habits to help conserve supplies.It also said installing more smart meters and fixing leaks would not be enough, with England projected to face a daily shortfall of five billion litres by 2055.
How can I reduce my water usage?England needs more hosepipe bans and smart water meters - watchdog
Prof Benjamin Gardner, lead author of the report and professor of psychology at the University of Surrey, said: "Most people don't know how much water they use. "The sector has focused on smart meters, which will raise awareness of water use – but smart meters alone won't cut it."The real challenge is in helping people to better recognise and understand how they use water and supporting them to continue doing their everyday activities, but in a more water-wise way. "To do that, the sector needs to make better use of behavioural science."
'The human factor'
It suggests focussing on issues such as fixing leaks in their homes, taking shorter showers and not flushing toilets so often, and says the water industry should focus on technology to work alongside these changes.Nicci Russell from Waterwise, a non-profit organisation which promotes water efficiency that took part in the study, said: "Research into behaviour helps us design smarter policies, technologies and communications that support people to use water more wisely."We can't afford to ignore the human factor. Water efficiency isn't just about infrastructure - it's about people, choices, habits, and values."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

This is the best time to take an exam to boost your chances of passing, study finds
This is the best time to take an exam to boost your chances of passing, study finds

The Independent

time10 hours ago

  • The Independent

This is the best time to take an exam to boost your chances of passing, study finds

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice Midday may be the best time to take an oral exam, interview for a job, or even go on trial, a new study has found. Researchers at Italy's University of Messina found a significant difference in students' pass rates in the late morning compared to early morning or late afternoon. At 12pm the students' passing rate was 72 per cent, compared to 54 per cent at 8am and 51 per cent at 4pm. Pass rates at 11am and 1pm were slightly lower at 67 per cent. 'We show that academic assessment outcomes vary systematically across the day, with a clear peak in passing rates around midday,' said Professor Carmelo Mario Vicario. 'Students were more likely to pass in late morning compared with early morning or late afternoon,' he said. 'We believe this pattern could extend to job interviews or any evaluative process scheduled throughout the day.' The study was based on the outcome of 104,552 assessments delivered by 680 examiners for 1,243 courses. The researchers chose to look at university oral exams, which are more subjective and aren't marked solely on correct answers, but also on delivery. It follows research showing that judges are more likely to rule in favour of a defendant at the start of sessions or after meal breaks. However, it is thought that this could also come down to the types of cases that are heard at different times of day. The study's author believes the findings could extend to job interviews ( Getty/iStock ) While the study could not identify the exact cause, it said the midday peak was consistent with evidence that cognitive performance improves over the morning and declines during the afternoon. The report said this could be due to the students' falling energy levels, as well as professors', who may give a harsher mark if they are experiencing decision fatigue. Researchers also said that it could be a result of students and professors competing chronotypes, the body's natural preference of sleeping times. 'People in their early 20s are usually night owls, while people in their 40s or older tend to be morning larks. The students might be least cognitively sharp at the time when the professors are most alert.' Prof Vicario suggested that to counteract these effects, students would benefit from better sleep, mental breaks, and scheduling exams outside of personal low periods. 'For institutions, delaying morning sessions or clustering key assessments in the late morning may improve outcomes. 'We believe this pattern could extend to job interviews or any evaluative process scheduled throughout the day. 'We would be very interested in investigating whether hiring decisions, too, fluctuate in fairness or outcome depending on time of day.'

The NHS change that could prevent 6,500 cancer cases each year
The NHS change that could prevent 6,500 cancer cases each year

The Independent

time11 hours ago

  • The Independent

The NHS change that could prevent 6,500 cancer cases each year

A new study suggests that thousands of breast cancer cases could be prevented annually in the UK by expanding eligibility for risk-reducing mastectomies (RRM). The research indicates that approximately 6,500 cases could be averted each year if RRM was more widely adopted beyond current genetic predispositions. Currently, RRM is primarily offered to women with BRCA1, BRCA2, or PALB2 genes, but the study proposes including those with other high-risk genes like ATM and CHEK2. The study also highlights that a combination of factors, including family history, parity, breastfeeding, and mammogram density, should be considered for RRM eligibility. Researchers from Queen Mary University of London and the London School of Hygiene and Tropical Medicine found RRM to be cost-effective for women aged 30-55 with a lifetime breast cancer risk of 35 per cent or more.

‘Risk-reducing' surgery could prevent thousands of breast cancer cases
‘Risk-reducing' surgery could prevent thousands of breast cancer cases

The Independent

time11 hours ago

  • The Independent

‘Risk-reducing' surgery could prevent thousands of breast cancer cases

Thousands of breast cancer cases could be averted each year if more women were offered 'risk-reducing' breast removal surgery, a new study suggests. This intervention, known as a mastectomy, is currently used to treat existing cancer or offered to those with a high genetic predisposition, specifically women carrying the BRCA1, BRCA2, or PALB2 genes. The analysis indicates that approximately 6,500 cases of breast cancer could be prevented annually if preventative mastectomies were more widely adopted. Crucially, the research proposes expanding eligibility beyond the currently recognised genetic markers. Women with other genes linked to increased risk, such as ATM, CHEK2, RAD51C, and RAD51D, may also benefit. Furthermore, the study highlights that a combination of other factors, including a family history of breast cancer, parity (number of children), breastfeeding history, and mammogram density, should be considered in assessing a woman's overall high risk for the disease, potentially making them candidates for risk-reducing mastectomies. Women in the UK have an 11 per cent chance of developing breast cancer across their lifetime. Medics can calculate a woman's risk of breast cancer using tools which combine the effect of various risk factors. Researchers from Queen Mary University of London and the London School of Hygiene and Tropical Medicine (LSHTM) found that if health officials could identify all women aged 30 to 55 who have a 35 per cent or higher risk of breast cancer, and they all went on to have RRM, then an estimated 6,538 breast cancer cases could be prevented in the UK each year. This is the equivalent of around 11 per cent of the 59,000 women in the UK who are diagnosed with breast cancer each year. The academics point out that women who have one of the other genes linked to breast cancer, who may be at high risk of disease, could potentially be found by a mechanism called 'cascade testing' – where genetic tests are offered to family members of women who have been found to have these different genes linked to breast cancer. The economic evaluation study, published in the journal JAMA Oncology, concludes: 'Undergoing RRM appears cost-effective for women at 30-55 years with a lifetime BC-risk 35 per cent (or more). 'The results could have significant clinical implications to expand access to RRM beyond BRCA1/BRCA2/PALB2 pathogenic variant carriers.' Corresponding author on the paper, Professor Ranjit Manchanda, professor of gynaecological oncology at Queen Mary and consultant gynaecological oncologist, said: 'We for the first time define the risk at which we should offer RRM. 'Our results could have significant clinical implications to expand access to mastectomy beyond those patients with known genetic susceptibility in high penetrance genes- BRCA1/ BRCA2/ PALB2 – who are traditionally offered this. 'This could potentially prevent can potentially prevent (around) 6500 breast cancer cases annually in UK women. 'We recommend that more research is carried out to evaluate the acceptability, uptake, and long-term outcomes of RRM among this group'. Dr Rosa Legood, associate professor in health economics at LSHTM, added: 'Undergoing RRM is cost-effective for women (aged) 30 to 55-years with a lifetime breast cancer risk of 35 per cent or more. 'These results can support additional management options for personalised breast cancer risk prediction enabling more women at increased risk to access prevention.' Women deemed to be at high risk of breast cancer can also be offered regular screening and medication. Louise Grimsdell, Breast Cancer Now senior clinical nurse specialist, said: 'While this modelling provides valuable insights into the cost-effectiveness of risk-reducing mastectomy for women with a high risk of developing breast cancer, each individual must be offered all risk-management options that are suitable for them. 'Choosing to have risk-reducing surgery is a complex and deeply personal decision that comes with emotional and physical implications. 'So, it's vital women can consider all their options, including screening and risk-reducing medications, and are supported by their clinician to make an informed decision that's right for them. 'It's also crucial that the unacceptably long waits that far too many women who chose risk-reducing surgery are facing are urgently tackled.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store